Citations (366)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (23)
Felix J. Tsai, Marcus Jaeger, Teresa Coelho, Evan T. Powers & Jeffery W. Kelly. (2023) Tafamidis concentration required for transthyretin stabilisation in cerebrospinal fluid. Amyloid 30:3, pages 279-289.
Read now
Read now
Amanda Lloji, Jayakumar Sreenivasan, Joel Novograd, Wilbert S. Aronow, Stephen Pan & Gregg M. Lanier. (2022) Heart failure with preserved ejection fraction: key stumbling blocks for experimental drugs in clinical trials. Expert Opinion on Investigational Drugs 31:5, pages 463-474.
Read now
Read now
James C. Ross, David F. Hutt, Maria Burniston, Simona F. Grigore, Marianna Fontana, Joanne Page, Philip N. Hawkins, Janet A. Gilbertson, Dorota Rowczenio & Julian D. Gillmore. (2022) The role of serial 99mTc-DPD scintigraphy in monitoring cardiac transthyretin amyloidosis. Amyloid 29:1, pages 38-49.
Read now
Read now
Arianna Burton, Adam Castaño, Marianna Bruno, Steve Riley, Jennifer Schumacher, Marla B Sultan, Sandi See Tai, Daniel P Judge, Jignesh K Patel & Jeffery W Kelly. (2021) Drug Discovery and Development in Rare Diseases: Taking a Closer Look at the Tafamidis Story. Drug Design, Development and Therapy 15, pages 1225-1243.
Read now
Read now
Amandeep Godara, Ron I. Riesenburger, Diana X. Zhang, Cindy Varga, Teresa Fogaren, Nauman S. Siddiqui, Anthony Yu, Andy Wang, Michael Mastroianni, Richard Dowd, Tara J. Nail, Ellen D. McPhail, Paul J. Kurtin, Jason D. Theis, Denis Toskic, Knarik Arkun, Monika Pilichowska, James Kryzanski, Ayan R. Patel & Raymond Comenzo. (2021) Association between spinal stenosis and wild-type ATTR amyloidosis. Amyloid 28:4, pages 226-233.
Read now
Read now
Shojiro Ichimata, Yukiko Hata, Keiichi Hirono, Yoshiaki Yamaguchi & Naoki Nishida. (2021) Clinicopathological features of clinically undiagnosed sporadic transthyretin cardiac amyloidosis: a forensic autopsy-based series. Amyloid 28:2, pages 125-133.
Read now
Read now
Tamer Rezk, Marianna Fontana & Julian D. Gillmore. (2021) A review of the criteria for non-invasive diagnosis of cardiac transthyretin amyloidosis. Expert Opinion on Orphan Drugs 9:3, pages 87-94.
Read now
Read now
Luke T. Nelson, Ryan J. Paxman, Jin Xu, Bill Webb, Evan T. Powers & Jeffery W. Kelly. (2021) Blinded potency comparison of transthyretin kinetic stabilisers by subunit exchange in human plasma. Amyloid 28:1, pages 24-29.
Read now
Read now
Avery A Rizio, Lynne E Broderick, Michelle K White & Tiffany P Quock. (2020) Content Validation of the ATTR Amyloidosis Patient Symptom Survey: Findings from Patient and Clinician Cognitive Debriefing Interviews. Patient Related Outcome Measures 11, pages 149-160.
Read now
Read now
Brett W. Sperry & Kyle Lehenbauer. (2020) Aortic Stenosis and Amyloidosis: Underdiagnosed and Underreported. Structural Heart 4:6, pages 515-517.
Read now
Read now
Trine Pilgaard, Mikkel Hasse Pedersen & Steen Hvitfeldt Poulsen. (2020) Diagnostic and lifetime hospital costs of patients suffering from wild-type transthyretin amyloid cardiomyopathy in Denmark. Journal of Medical Economics 23:10, pages 1084-1091.
Read now
Read now
Robert Adam, Alice Munteanu, Raluca Mititelu, Sebastian Onciul, Dan Deleanu, Vlad Anton Iliescu, Bogdan A Popescu & Ruxandra Jurcut. (2020) Severe Aortic Stenosis and ATTRwt Amyloidosis – Beware in the Aging: A Case Report and Review of the Literature. Clinical Interventions in Aging 15, pages 1863-1872.
Read now
Read now
Sophie Bartier, Diane Bodez, Mounira Kharoubi, Florence Canouï-Poitrine, Véronique Chatelin, Carole Henrion, André Coste, Thibaud Damy & Emilie Béquignon. (2019) Pharyngo-laryngeal involvement in systemic amyloidosis with cardiac involvement: a prospective observational study. Amyloid 26:4, pages 216-224.
Read now
Read now
James C. Ross, David F. Hutt, Maria Burniston, Joanne Page, Jennifer A. Steeden, Julian D. Gillmore, Ashutosh D. Wechalekar, Philip N. Hawkins & Marianna Fontana. (2018) Quantitation of 99mTc-DPD uptake in patients with transthyretin-related cardiac amyloidosis. Amyloid 25:3, pages 203-210.
Read now
Read now
Mario Nuvolone & Giampaolo Merlini. (2017) Emerging therapeutic targets currently under investigation for the treatment of systemic amyloidosis. Expert Opinion on Therapeutic Targets 21:12, pages 1095-1110.
Read now
Read now
Francesca Lavatelli & Giampaolo Merlini. (2016) Advances in proteomic study of cardiac amyloidosis: progress and potential. Expert Review of Proteomics 13:11, pages 1017-1027.
Read now
Read now
Philip N. Hawkins, Yukio Ando, Angela Dispenzeri, Alejandra Gonzalez-Duarte, David Adams & Ole B. Suhr. (2015) Evolving landscape in the management of transthyretin amyloidosis. Annals of Medicine 47:8, pages 625-638.
Read now
Read now
Taxiarchis V Kourelis & Morie A Gertz. (2015) Improving strategies for the diagnosis of cardiac amyloidosis. Expert Review of Cardiovascular Therapy 13:8, pages 945-961.
Read now
Read now
Daniel R. Jacobson, Alice A. Alexander, Clement Tagoe & Joel N. Buxbaum. (2015) Prevalence of the amyloidogenic transthyretin (TTR) V122I allele in 14 333 African–Americans. Amyloid 22:3, pages 171-174.
Read now
Read now
Rodney H. Falk. (2012) Senile systemic amyloidosis: are regional differences real or do they reflect different diagnostic suspicion and use of techniques?. Amyloid 19:sup1, pages 68-70.
Read now
Read now
Shu-ichi Ikeda, Yoshiki Sekijima, Kana Tojo & Jun Koyama. (2011) Diagnostic value of abdominal wall fat pad biopsy in senile systemic amyloidosis. Amyloid 18:4, pages 211-215.
Read now
Read now
Y. Su, Y. Horibata, M. Ueda, M. Tasaki, Y. Misumi, J. Guo, M. Shono, H. Jono, K. Obayashi, H. Ogawa & Y. Ando. (2011) Transthyretin-derived amyloid deposition in the heart of an elderly Japanese population. Amyloid 18:sup1, pages 180-181.
Read now
Read now
L. H. Connors, G. Doros, F. Sam, A. Badiee, D. C. Seldin & M. Skinner. (2011) Clinical features and survival in senile systemic amyloidosis: comparison to familial transthyretin cardiomyopathy. Amyloid 18:sup1, pages 157-159.
Read now
Read now
Articles from other publishers (343)
Michael A. Smith & Neil G. Feinglass. (2024) Perioperative implications of amyloidosis and amyloid cardiomyopathy: A review for anesthesiologists. Journal of Clinical Anesthesia 92, pages 111271.
Crossref
Crossref
Hritvik Jain, Murali Mohan Rama Krishna Reddy, Rohit Chandra Dey, Jyoti Jain, Zaid Shakhatreh, Sarbagya Manandhar, Purushottam Neupane, Madeeha Subhan Waleed, Rukesh Yadav, Biki Kumar Sah & Rukam Mahawa. (2024) Exploring Transthyretin Amyloid Cardiomyopathy: A Comprehensive Review of the Disease and Upcoming Treatments. Current Problems in Cardiology 49:1, pages 102057.
Crossref
Crossref
Stéphanie Cazalbou, Louise Naccache, Sandrine Sourdet, Eve Cariou, Pauline Fournier, Fati Nourhashemi, Laurent Balardy, Olivier Toulza, Olivier Lairez & Zara Steinmeyer. (2023) Frailty in Older Patients with Transthyretin Cardiac Amyloidosis. Journal of Clinical Medicine 12:24, pages 7507.
Crossref
Crossref
Meity Ardiana, Asiyah Nurul Fadila, Zakirah Zuhra, Nabilla Merdika Kusuma, Made Edgard Surya Erlangga Rurus & Delvac Oceandy. (2023) Non-coding RNA therapeutics in cardiovascular diseases and risk factors: Systematic review. Non-coding RNA Research 8:4, pages 487-506.
Crossref
Crossref
Eriku Yamada, Tomoyuki Umemoto, Towako Taguchi, Iichiroh Onishi, Akiko Yamamoto, Kazuya Tsukamoto, Takuya Ibara, Toru Sasaki, Hidetoshi Kaburagi, Yasuhiro Maejima, Tetsuo Sasano, Kenichi Ohashi, Toshitaka Yoshii, Akimoto Nimura & Koji Fujita. (2023) Prevalence of amyloid deposition and cardiac amyloidosis in shoulder disease compared to carpal tunnel syndrome. JSES International.
Crossref
Crossref
Francisca Pinheiro, Nathalia Varejão, Adrià Sánchez-Morales, Filipa Bezerra, Susanna Navarro, Adrián Velázquez-Campoy, Félix Busqué, Maria Rosário Almeida, Ramon Alibés, David Reverter, Irantzu Pallarès & Salvador Ventura. (2023) PITB: A high affinity transthyretin aggregation inhibitor with optimal pharmacokinetic properties. European Journal of Medicinal Chemistry 261, pages 115837.
Crossref
Crossref
Gareth J. Morgan. (2023) Understanding and Overcoming Biochemical Diversity in AL Amyloidosis. Israel Journal of Chemistry.
Crossref
Crossref
Pablo Garcia-Pavia, Marla B. Sultan, Balarama Gundapaneni, Yoshiki Sekijima, Federico Perfetto, Mazen Hanna & Ronald Witteles. (2023) Tafamidis Efficacy Among Octogenarian Patients in the Phase 3 ATTR-ACT and Ongoing Long-Term Extension Study. JACC: Heart Failure.
Crossref
Crossref
Tanveer Mir, Mohammed Uddin, Tarec Micho Ulbeh, Eskara Perveiz, Prateek Lohia, Yasar Sattar, Shady Abohashem, Waqas Ullah, Kameswari Maganti, Waqas T. Qureshi & Nasser Lakis. (2023) Clinical Outcomes of Aortic Stenosis in Amyloidosis: A United States National Cohort Study. Heart, Lung and Circulation.
Crossref
Crossref
Pietro Costantini, Eleonora Ostillio, Léon Groenhoff, Anna Carmen Leonetti, Agnese Siani, Giulia De Zan, Marco Guglielmo & Alessandro Carriero. (2023) Aortic Stenosis and Amyloidosis: Role of MRI and CT in the Diagnosis of a Sneaky Association. Current Radiology Reports.
Crossref
Crossref
Frauke Czepluch. (2023) Kardiale ATTR-AmyloidoseTransthyretin amyloid cardiomyopathy. Die Innere Medizin 64:9, pages 823-829.
Crossref
Crossref
Stephan Dobner, Thomas Pilgrim, Daniel Hagemeyer, Dik Heg, Jonas Lanz, Nicole Reusser, Christoph Gräni, Ali Afshar‐Oromieh, Axel Rominger, Bettina Langhammer, David Reineke, Stephan Windecker & Stefan Stortecky. (2023) Amyloid Transthyretin Cardiomyopathy in Elderly Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation. Journal of the American Heart Association 12:16.
Crossref
Crossref
Nina Ajmone Marsan, Francesca Graziani, Maria Chiara Meucci, Hoi W. Wu, Rosa Lillo, Jeroen J. Bax, Francesco Burzotta, Massimo Massetti, J. Wouter Jukema & Filippo Crea. (2023) Valvular heart disease and cardiomyopathy: reappraisal of their interplay. Nature Reviews Cardiology.
Crossref
Crossref
Hiroki Usuku, Eiichiro Yamamoto, Daisuke Sueta, Kanako Imamura, Fumi Oike, Kyohei Marume, Masanobu Ishii, Shinsuke Hanatani, Yuichiro Arima, Seiji Takashio, Seitaro Oda, Hiroaki Kawano, Mitsuharu Ueda, Hirotaka Matsui & Kenichi Tsujita. (2023) Usefulness of automatic assessment for longitudinal strain to diagnose wild-type transthyretin amyloid cardiomyopathy. IJC Heart & Vasculature 47, pages 101227.
Crossref
Crossref
Shahzad Ahmad, Muddasir Ashraf, Salman Salehin, Syed Mustajab Hasan, Haleema Sadia, Wissam Khalife & Khaled F Chatila. (2023) Healthcare and economic burden of heart failure with amyloidosis: An insight from National Readmission Database. The American Journal of the Medical Sciences.
Crossref
Crossref
Aakash Bavishi, Celeste Witting, James Guo, Erik Wu, Jordan John, Madeline Jankowski, Abigail S. Baldridge, Daisy Meng & Kameswari Maganti. (2023) Predictive Value of Relative Apical Sparing of Longitudinal Strain on Echocardiography for Cardiac Amyloidosis. The American Journal of Cardiology 200, pages 66-71.
Crossref
Crossref
Anika Bilal & Richard E. Pratley. (2023) Newer Glucose-Lowering Therapies in Older Adults with Type 2 Diabetes. Endocrinology and Metabolism Clinics of North America 52:2, pages 355-375.
Crossref
Crossref
Junjun Quan, Dustin Gerber, Ang Li, Xupei Huang & Jie Tian. (2023) A green tea extract catechin EGCg: Therapeutic potential for pediatric cardiomyopathies. Pediatric Discovery 1:1.
Crossref
Crossref
Syed Bukhari. (2023) Cardiac amyloidosis: state-of-the-art review. Journal of Geriatric Cardiology 20:5, pages 361-375.
Crossref
Crossref
Frederick L. Ruberg, William S. Blaner, Codruta Chiuzan, Lawreen H. Connors, Andrew J. Einstein, Denise Fine, Stephen Helmke, Damian Kurian, Shivda Pandey, Farbod Raiszadeh, Carlos Rodriguez, Natalia Sabogal, Sergio Teruya, Morgan Winburn, Wendy K. Chung, Elizabeth Cohn, Edward J. Miller, Jeffery W. Kelly & Mathew S. Maurer. (2023) Design and Rationale the SCAN‐MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study. Journal of the American Heart Association 12:8.
Crossref
Crossref
Noritake Matsuda, Hideki Otsuka, Tamaki Otani, Shota Azane, Yamato Kunikane, Yoichi Otomi, Yuya Ueki, Masahiro Kubota, Masafumi Amano, Shusuke Yagi, Masataka Sata & Masafumi Harada. (2022) New quantitative indices of cardiac amyloidosis with 99mTc-pyrophosphate scintigraphy. Japanese Journal of Radiology 41:4, pages 428-436.
Crossref
Crossref
María del Carmen Navarro-Saez, Carlos Feijoo-Massó, Zully del Carmen Bravo Ferrer, Joan Carles Oliva Morera, Andrea María Balado González, Alba Palau-Domínguez, Laura Guillamon Toran, Ricard Comet Monte & Andreu Fernández-Codina. (2023) Trends in diagnosis of cardiac transthyretin amyloidosis: 3-year analysis of scintigraphic studies: Prevalence of myocardial uptake and its predictor factors. The International Journal of Cardiovascular Imaging 39:7, pages 1397-1404.
Crossref
Crossref
Yu Hashimoto, Takayuki Yamaji, Toshiro Kitagawa, Yukiko Nakano, Masato Kajikawa, Kenichi Yoshimura, Kazuaki Chayama, Chikara Goto, Syunsuke Tanigawa, Aya Mizobuchi, Takahiro Harada, Farina Mohamad Yusoff, Shinji Kishimoto, Tatsuya Maruhashi, Asuka Fujita, Toshio Uchiki, Ayumu Nakashima & Yukihito Higashi. (2023) Endothelial Function Is Preserved in Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy. Journal of Clinical Medicine 12:7, pages 2534.
Crossref
Crossref
Angelica Cersosimo, Andrea Bonelli, Carlo M. Lombardi, Antonella Moreo, Matteo Pagnesi, Daniela Tomasoni, Gianmarco Arabia, Enrico Vizzardi, Marianna Adamo, Davide Farina, Marco Metra & Riccardo M. Inciardi. (2023) Multimodality imaging in the diagnostic management of concomitant aortic stenosis and transthyretin-related wild-type cardiac amyloidosis. Frontiers in Cardiovascular Medicine 10.
Crossref
Crossref
Yevgeniy Brailovsky, Indranee Rajapreyar & Rene Alvarez. (2023) TTR Amyloidosis. JACC: Case Reports 10, pages 101759.
Crossref
Crossref
Michelle M. Kittleson, Frederick L. Ruberg, Amrut V. Ambardekar, Thomas H. Brannagan, Richard K. Cheng, John O. Clarke, Laura M. Dember, Janell Grazzini Frantz, Ray E. Hershberger, Mathew S. Maurer, Jose Nativi-Nicolau, Vaishali Sanchorawala & Farooq H. Sheikh. (2023) 2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis. Journal of the American College of Cardiology 81:11, pages 1076-1126.
Crossref
Crossref
Adam Ioannou, Marianna Fontana & Julian D. Gillmore. (2023) RNA Targeting and Gene Editing Strategies for Transthyretin Amyloidosis. BioDrugs 37:2, pages 127-142.
Crossref
Crossref
Rahul Bhambri, A. Carmine Colavecchia, Marianna Bruno, Yong Chen, Jose Alvir, Anuja Roy, Jason Kemner, Aaron Crowley, Darrin Benjumea & Lauren Gilstrap. (2023) Real-World Characteristics of Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy: An Analysis of Electronic Healthcare Records in the United States. American Journal of Cardiovascular Drugs 23:2, pages 197-206.
Crossref
Crossref
Mohamed Abdelghany, Magdy Abdelhamid, Adel Allam, Adel El Etriby, Sherif Hafez, Hany Ragy & Mohamed Sobhy. (2023) Detection and Diagnosis of Cardiac Amyloidosis in Egypt. Cardiology and Therapy 12:1, pages 197-213.
Crossref
Crossref
Xiaofang Xu, Huikang Xu & Zhaocai Zhang. (2023) Cerebral amyloid angiopathy-related cardiac injury: Focus on cardiac cell death. Frontiers in Cell and Developmental Biology 11.
Crossref
Crossref
Ming-Yue XU, Wei HUANG, Kan ZHANG, Dai ZHANG & Yun-Li XING. (2023) A misdiagnosed transthyretin in an elderly with myocardial hypertrophy and atrioventricular block: a case report. Journal of Geriatric Cardiology 20:2, pages 150-154.
Crossref
Crossref
Bertil Ladefoged, Tor Clemmensen, Anne Dybro, Charlotte Hartig‐Andreasen, Lone Kirkeby, Lars Christian Gormsen, Peter Bomholt, Julian Gillmore & Steen Hvitfeldt Poulsen. (2022)
Identification of wild‐type transthyretin cardiac amyloidosis in patients with carpal tunnel syndrome surgery (
CACTuS
)
. ESC Heart Failure 10:1, pages 234-244.
Crossref
Crossref
Serenelli Matteo, Cantone Anna, Sanguettoli Federico, Maio Daniele, Fabbri Gioele, Dal Passo Beatrice, Pavasini Rita, Tonet Elisabetta, Passarini Giulia, Rapezzi Claudio & Campo Gianluca. (2023) Stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: A systematic review. Frontiers in Cardiovascular Medicine 10.
Crossref
Crossref
Adam Ioannou, Marianna Fontana & Julian D Gillmore. (2023) Patisiran for the Treatment of Transthyretin-mediated Amyloidosis with Cardiomyopathy. Heart International 17:1, pages 27.
Crossref
Crossref
Ana Sofia Fernandes Ribeiro, Blanca Egea Zerolo, Fidel Lopez-Espuela, Raul Sanchez & Vitor S. Fernandes. (2023) Cardiac System during the Aging Process. Aging and disease, pages 0.
Crossref
Crossref
Thomas Zegkos, Thomas Gossios, Dimitris Ntelios, Despoina Parcharidou, Haralampos Karvounis & Georgios Efthimiadis. (2021) Wild-Type Transthyretin Amyloid Cardiomyopathy: The Gordian-Knot of Novel Therapeutic Regimens. Cardiology in Review 31:1, pages 36-41.
Crossref
Crossref
Marcus Vinicius Simões & Edileide Barros Correa. 2023. Amyloidosis and Fabry Disease. Amyloidosis and Fabry Disease
143
151
.
Mario Nuvolone, Maria Girelli & Giampaolo Merlini. (2022) Oral Therapy for the Treatment of Transthyretin-Related Amyloid Cardiomyopathy. International Journal of Molecular Sciences 23:24, pages 16145.
Crossref
Crossref
Trejeeve Martyn, Andres Carmona Rubio, Jerry D. Estep & Mazen Hanna. (2022) Opportunities for Earlier Diagnosis and Treatment of Cardiac Amyloidosis. Methodist DeBakey Cardiovascular Journal 18:5, pages 27-39.
Crossref
Crossref
Mark S. Taylor, Hasib Sidiqi, James Hare, Fiona Kwok, Bo Choi, Darren Lee, Jay Baumwol, Antonia S. Carroll, Steve Vucic, Pat Neely, Dariusz Korczyk, Liza Thomas, Peter Mollee, Graeme J. Stewart & Simon D. J. Gibbs. (2022) Current approaches to the diagnosis and management of amyloidosis. Internal Medicine Journal 52:12, pages 2046-2067.
Crossref
Crossref
Peter Luke, Mohammad Alkhalil & Christopher Eggett. (2022) Current and novel echocardiographic assessment of left ventricular systolic function in aortic stenosis—A comprehensive review. Echocardiography 39:12, pages 1470-1480.
Crossref
Crossref
Hirokazu Ozaki, Nobuyuki Mitsui, Manabu Kinoshita, Mishie Tanino & Teruo Kimura. (2022) Amyloid deposition at the carotid artery in an ATTRwt amyloidosis patient: a case report. Journal of Surgical Case Reports 2022:12.
Crossref
Crossref
Kifah Hussain, Victor Macrinici, Lucas Wathen, Senthil S. Balasubramanian, Iva Minga, Safwan Gaznabi, Esther Kwak, Chi-Hsiung Wang, Suha Haider Iqbal, Amit Pursnani & Nitasha Sarswat. (2022) Impact of Tafamidis on Survival in a Real-World Community-Based Cohort. Current Problems in Cardiology 47:12, pages 101358.
Crossref
Crossref
Satoru Watanabe, Kenichi Nakajima, Hiroshi Wakabayashi, Hiroto Yoneyama, Shohei Yoshida, Junji Komatsu, Takahiro Konishi, Anri Inaki & Seigo Kinuya. (2021) Volumetric evaluation of 99mTc-pyrophosphate SPECT/CT for transthyretin cardiac amyloidosis: Methodology and correlation with cardiac functional parameters. Journal of Nuclear Cardiology 29:6, pages 3102-3110.
Crossref
Crossref
Christian Nitsche. (2022) How prevalent is cardiac amyloidosis and which patients should be screened?. European Journal of Heart Failure 24:12, pages 2352-2354.
Crossref
Crossref
Alberto Aimo, Marco Merlo, Aldostefano Porcari, Georgios Georgiopoulos, Linda Pagura, Giuseppe Vergaro, Gianfranco Sinagra, Michele Emdin & Claudio Rapezzi. (2022) Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta‐analysis of screening studies. European Journal of Heart Failure 24:12, pages 2342-2351.
Crossref
Crossref
Adam Ioannou, Rishi K. Patel, Yousuf RazviAldostefano Porcari, Gianfranco Sinagra, Lucia VenneriFrancesco BanderaAmbra Masi, Georgina E. WilliamsSophie O’Beara, Sharmananthan Ganesananthan, Paolo MassaDaniel Knight, Ana Martinez-NaharroTushar Kotecha, Liza ChackoJames Brown, Muhammad U. Rauf, Charlotte Manisty, James MoonHelen LachmannAshutosh WechelakarAviva Petrie, Carol WhelanPhilip N. HawkinsJulian D. Gillmore & Marianna Fontana. (2022) Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 Years. Circulation 146:22, pages 1657-1670.
Crossref
Crossref
Aldostefano Porcari, Valentina Allegro, Riccardo Saro, Guerino Giuseppe Varrà, Linda Pagura, Maddalena Rossi, Andrea Lalario, Francesca Longo, Renata Korcova, Matteo Dal Ferro, Andrea Perkan, Franca Dore, Rossana Bussani, Giovanni Maria De Sabbata, Francesco Zaja, Marco Merlo & Gianfranco Sinagra. (2022) Evolving trends in epidemiology and natural history of cardiac amyloidosis: 30-year experience from a tertiary referral center for cardiomyopathies. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Dia A. Smiley, Carlos M. Rodriguez & Mathew S. Maurer. (2022) Transthyretin Cardiac Amyloidosis. Cardiology Clinics 40:4, pages 541-558.
Crossref
Crossref
Maurizio Pieroni, Michele Ciabatti, Elisa Saletti, Valentina Tavanti, Pasquale Santangeli, Lucia Martinese, Francesco Liistro, Iacopo Olivotto & Leonardo Bolognese. (2022) Beyond Sarcomeric Hypertrophic Cardiomyopathy: How to Diagnose and Manage Phenocopies. Current Cardiology Reports 24:11, pages 1567-1585.
Crossref
Crossref
Marcus A. C. Williams, Bairavi Shankar, Joban Vaishnav & Mark J. Ranek. (2022) Current and potential therapeutic strategies for transthyretin cardiac amyloidosis. Frontiers in Drug Discovery 2.
Crossref
Crossref
Alberto Aimo, Vincenzo Castiglione, Claudio Rapezzi, Maria Franzini, Giorgia Panichella, Giuseppe Vergaro, Julian Gillmore, Marianna Fontana, Claudio Passino & Michele Emdin. (2022) RNA-targeting and gene editing therapies for transthyretin amyloidosis. Nature Reviews Cardiology 19:10, pages 655-667.
Crossref
Crossref
Francesco Cannata, Mauro Chiarito, Giuseppe Pinto, Alessandro Villaschi, Jorge Sanz‐Sánchez, Fabio Fazzari, Damiano Regazzoli, Antonio Mangieri, Renato M. Bragato, Antonio Colombo, Bernhard Reimers, Gianluigi Condorelli & Giulio G. Stefanini. (2022) Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta‐analysis. ESC Heart Failure 9:5, pages 3188-3197.
Crossref
Crossref
Horacio E. Adrogue. (2022) Amyloidosis of the Heart and Kidney. Methodist DeBakey Cardiovascular Journal 18:4, pages 27-33.
Crossref
Crossref
S. Oghina, M.A. Delbarre, E. Poullot, K. Belhadj, P. Fanen & T. Damy. (2022) Les amyloses cardiaques : état des lieux en 2022. La Revue de Médecine Interne 43:9, pages 537-544.
Crossref
Crossref
M. Y. Henein, B. Pilebro & Per Lindqvist. (2022) Disease progression in cardiac morphology and function in heart failure: ATTR cardiac amyloidosis versus hypertensive left ventricular hypertrophy. Heart and Vessels 37:9, pages 1562-1569.
Crossref
Crossref
Alessia Argiro’, Mattia Zampieri, Carlotta Mazzoni, Tullio Catalucci, Beatrice Biondo, Alessia Tomberli, Martina Gabriele, Carlo Di Mario, Federico Perfetto & Francesco Cappelli. (2022) Red flags for the diagnosis of cardiac amyloidosis: simple suggestions to raise suspicion and achieve earlier diagnosis. Journal of Cardiovascular Medicine 23:8, pages 493-504.
Crossref
Crossref
Raghed Almamlouk, Tarek Kashour, Sawsan Obeidat, Melanie C. Bois, Joseph J. Maleszewski, Osama A. Omrani, Rana Tleyjeh, Elie Berbari, Zaher Chakhachiro, Bassel Zein-Sabatto, Dana Gerberi, Imad M. Tleyjeh, Alberto E. Paniz Mondolfi, Aloke V. Finn, Amaro Nunes Duarte-Neto, Amy V. Rapkiewicz, Andrea Frustaci, Arthur-Atilla Keresztesi, Brian Hanley, Bruno Märkl, Christelle Lardi, Clare Bryce, Diana Lindner, Diego Aguiar, Dirk Westermann, Edana Stroberg, Eric J. Duval, Esther Youd, Gaetano Pietro Bulfamante, Isabelle Salmon, Johann Auer, Joseph J. Maleszewski, Klaus Hirschbühl, Lara Absil, Lisa M. Barton, Luiz Fernando Ferraz da Silva, Luiza Moore, Marisa Dolhnikoff, Martin Lammens, Melanie C. Bois, Michael Osborn, Myriam Remmelink, Paulo Hilario Nascimento Saldiva, Philippe G. Jorens, Randall Craver, Renata Aparecida de Almeida Monteiro, Roberto Scendoni, Sanjay Mukhopadhyay, Tadaki Suzuki, Thais Mauad, Tony Fracasso & Zachary Grimes. (2022) COVID-19–Associated cardiac pathology at the postmortem evaluation: a collaborative systematic review. Clinical Microbiology and Infection 28:8, pages 1066-1075.
Crossref
Crossref
Nicolai B. Grether, Felix Napravnik, Thomas Imhof, Reinhold P. Linke, Jan H. Bräsen, Jessica Schmitz, Maike Dohrn, Christian Schneider, Martin K. R. Svačina, Jörg Stetefeld, Manuel Koch & Helmar C. Lehmann. (2022) Amyloidogenicity assessment of transthyretin gene variants. Annals of Clinical and Translational Neurology 9:8, pages 1252-1263.
Crossref
Crossref
Christine P. Shen, Christopher T. Vanichsarn, Amitabh C. Pandey, Kristen Billick, David S. Rubenson, Rajeev C. Mohan, James Thomas Heywood & Ajay V. Srivastava. (2022) Wild type cardiac amyloidosis: is it time to order a nuclear technetium pyrophosphate SPECT imaging study?. The International Journal of Cardiovascular Imaging 39:1, pages 201-208.
Crossref
Crossref
Steven Law, Melanie Bezard, Aviva Petrie, Liza Chacko, Oliver C Cohen, Sriram Ravichandran, Olabisi Ogunbiyi, Mounira Kharoubi, Sashiananthan Ganeshananthan, Sharmananthan Ganeshananthan, Janet A Gilbertson, Dorota Rowczenio, Ashutosh Wechalekar, Ana Martinez-Naharro, Helen J Lachmann, Carol J Whelan, David F Hutt, Philip N Hawkins, Thibaud Damy, Marianna Fontana & Julian D Gillmore. (2022) Characteristics and natural history of early-stage cardiac transthyretin amyloidosis. European Heart Journal 43:27, pages 2622-2632.
Crossref
Crossref
Anuja RoyAndrew PetersonNick MarchantJose AlvirRahul BhambriZach BredlDarrin BenjumeaJason KemnerBhash Parasuraman. (2022) Baseline characteristics and secondary medication adherence among Medicare patients diagnosed with transthyretin amyloid cardiomyopathy and/or receiving tafamidis prescriptions: A retrospective analysis of a Medicare cohort. Journal of Managed Care & Specialty Pharmacy 28:7, pages 766-777.
Crossref
Crossref
Xiaokai Zhang, Yang Zhang, Aijun Sun & Junbo Ge. (2022) The effects of nicotinamide adenine dinucleotide in cardiovascular diseases: Molecular mechanisms, roles and therapeutic potential. Genes & Diseases 9:4, pages 959-972.
Crossref
Crossref
Adam Ioannou, Rishi Patel, Julian D. Gillmore & Marianna Fontana. (2022) Imaging-Guided Treatment for Cardiac Amyloidosis. Current Cardiology Reports 24:7, pages 839-850.
Crossref
Crossref
Maddalena Rossi, Guerino Giuseppe Varrà, Aldostefano Porcari, Riccardo Saro, Linda Pagura, Andrea Lalario, Franca Dore, Rossana Bussani, Gianfranco Sinagra & Marco Merlo. (2022) Re-Definition of the Epidemiology of Cardiac Amyloidosis. Biomedicines 10:7, pages 1566.
Crossref
Crossref
Hiroaki Matsushita, Yohei Misumi, Teruaki Masuda, Masamitsu Okada, Fumika Inoue, Mitsuharu Ueda & Yukio Ando. (2022) Urinary Transthyretin as a Biomarker in ATTRv Val50Met Amyloidosis. Pathophysiology 29:3, pages 333-343.
Crossref
Crossref
Giuseppe Limongelli, Rachele Adorisio, Chiara Baggio, Barbara Bauce, Elena Biagini, Silvia Castelletti, Silvia Favilli, Massimo Imazio, Michele Lioncino, Marco Merlo, Emanuele Monda, Iacopo Olivotto, Vanda Parisi, Francesco Pelliccia, Cristina Basso, Gianfranco Sinagra, Ciro Indolfi & Camillo Autore. (2022) Diagnosis and Management of Rare Cardiomyopathies in Adult and Paediatric Patients. A Position Paper of the Italian Society of Cardiology (SIC) and Italian Society of Paediatric Cardiology (SICP). International Journal of Cardiology 357, pages 55-71.
Crossref
Crossref
Olli Suomalainen, Jaagup Pilv, Antti Loimaala, Sorjo Mätzke, Tiina Heliö & Valtteri Uusitalo. (2020) Prognostic significance of incidental suspected transthyretin amyloidosis on routine bone scintigraphy. Journal of Nuclear Cardiology 29:3, pages 1021-1029.
Crossref
Crossref
Sergey N. Tereshchenko, Igor V. Zhirov, Olga M. Moiseeva, Tatiana V. Adasheva, Alexey A. Ansheles, Olga L. Barbarash, Albert S. Galyavich, Alexandra Ia. Gudkova, Dmitry A. Zateyshchikov, Anna A. Kostareva, Svetlana N. Nasonova, Sergey V. Nedogoda, Tamara B. Pecherina, Daria V. Ryzhkova & Vladimir B. Sergienko. (2022) Practical guidelines for the diagnosis and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM or transthyretin cardiac amyloidosis). Terapevticheskii arkhiv 94:4, pages 584-595.
Crossref
Crossref
Yasuhiro Tsuji, Noboru Nishiwaki, Kozo Kaneda & Shigeo Nagasaka. (2022) An Autopsy Case of Transthyretin-Related Cardiac Amyloidosis (TTR-CA), Which Fell into Low-Output Syndrome after Cardiac Surgery開心術後に低心拍出状態に陥り，トランスサイレチン関連心アミロイドーシス（transthyretin-related cardiac amyloidosis）と診断された1剖検例. Japanese Journal of Cardiovascular Surgery 51:3, pages 157-162.
Crossref
Crossref
Cristina Basso & James R. Stone. (2022) Autopsy in the era of advanced cardiovascular imaging. European Heart Journal.
Crossref
Crossref
Ravi J. Shah & Stephen Pan. (2022) Sex and the protein: Evaluating the role of sex in the diagnosis, presentation, and clinical outcomes in cardiac amyloidosis. International Journal of Cardiology 355, pages 28-29.
Crossref
Crossref
Valtteri Uusitalo, Olli Suomalainen, Antti Loimaala, Sorjo Mätzke & Tiina Heliö. (2022) Prognostic Value of 99mTc-HMDP Scintigraphy in Elderly Patients With Chronic Heart Failure. Heart, Lung and Circulation 31:5, pages 629-637.
Crossref
Crossref
Roxana Cristina Rimbas, Anca Balinisteanu, Stefania Lucia Magda, Simona Ionela Visoiu, Andrea Olivia Ciobanu, Elena Beganu, Alina Ioana Nicula & Dragos Vinereanu. (2022) New Advanced Imaging Parameters and Biomarkers—A Step Forward in the Diagnosis and Prognosis of TTR Cardiomyopathy. Journal of Clinical Medicine 11:9, pages 2360.
Crossref
Crossref
Claudio RAPEZZI, Giuseppe VERGARO, Michele EMDIN, Gioele FABBRI, Anna CANTONE, Federico SANGUETTOLI & Alberto AIMO. (2022) The revolution of ATTR amyloidosis in cardiology: certainties, gray zones and perspectives. Minerva Cardiology and Angiology 70:2.
Crossref
Crossref
Abdullah Shehab, Albena Todorova, Aysha Ahmed, Esther Gonzalez-Lopez, Fabian Knebel, Haluk Alibazoglu, Hani Sabbour, Ingy Romany, Isabel Krsnik, Juwairiah Al Ali, Khaldoon Al Humood, Marianna Fontana, Matlooba Al Zidjali & Nishant R. Shah. (2022) Pearls from the First Gulf Cardiac Amyloidosis Summit 2021. New Emirates Medical Journal 3:1, pages 1-11.
Crossref
Crossref
Takashi Kudo & Aiganym Imakhanova. (2020) Quantification of amyloid deposition using bone scan agents. Journal of Nuclear Cardiology 29:2, pages 515-518.
Crossref
Crossref
Lidia Ciccone, Susanna Nencetti, Caterina Camodeca, Gabriella Ortore, Doretta Cuffaro, Simone Socci & Elisabetta Orlandini. (2022) Synthesis and Evaluation of Monoaryl Derivatives as Transthyretin Fibril Formation Inhibitors. Pharmaceutical Chemistry Journal 56:1, pages 38-47.
Crossref
Crossref
Grant Duffy, Paul P. Cheng, Neal Yuan, Bryan He, Alan C. Kwan, Matthew J. Shun-Shin, Kevin M. Alexander, Joseph Ebinger, Matthew P. Lungren, Florian Rader, David H. Liang, Ingela Schnittger, Euan A. Ashley, James Y. Zou, Jignesh Patel, Ronald Witteles, Susan Cheng & David Ouyang. (2022) High-Throughput Precision Phenotyping of Left Ventricular Hypertrophy With Cardiovascular Deep Learning. JAMA Cardiology 7:4, pages 386.
Crossref
Crossref
Paul J. ScheelIIIIII, Monica Mukherjee, Allison G. Hays & Joban Vaishnav. (2022) Multimodality Imaging in the Evaluation and Prognostication of Cardiac Amyloidosis. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Chukwuemeka A. Obi, William C. Mostertz, Jan M. Griffin & Daniel P. Judge. (2022) ATTR Epidemiology, Genetics, and Prognostic Factors. Methodist DeBakey Cardiovascular Journal 18:2, pages 17-26.
Crossref
Crossref
Ko Harada, Hideharu Hagiya, Toshihiro Koyama & Fumio Otsuka. (2022)
Trends in the amyloidosis mortality rate in
J
apan: A nationwide observational study from 1998 to 2019
. Geriatrics & Gerontology International 22:3, pages 246-250.
Crossref
Crossref
Mattia Zampieri, Alessia Argirò, Marco Allinovi, Luigi Tassetti, Chiara Zocchi, Martina Gabriele, Valentina Andrei, Carlo Fumagalli, Carlo Di Mario, Alessia Tomberli, Iacopo Olivotto, Federico Perfetto & Francesco Cappelli. (2022) Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis. International Journal of Cardiology 351, pages 71-77.
Crossref
Crossref
Jamie Sin-Ying Ho, Qianyi Kor, William KF. Kong, Yoke Ching Lim, Mark Yan-Yee Chan, Nicholas LX. Syn, Jinghao Nicholas Ngiam, Nicholas WS. Chew, Tiong-Cheng Yeo, Ping Chai, Kian-Keong Poh, Raymond CC. Wong, Weiqin Lin & Ching-Hui Sia. (2022) Prevalence and outcomes of concomitant cardiac amyloidosis and aortic stenosis: A systematic review and meta-analysis. Hellenic Journal of Cardiology 64, pages 67-76.
Crossref
Crossref
Eva Strickler, Ernest Tsiaze, Gerrit Hellige, Dominik Zumstein, Dominik Waldmeier & Nisha Arenja. 2022. Amyloidosis - History and Perspectives. Amyloidosis - History and Perspectives.
Nariman Sepehrvand, Erik Youngson, Nowell Fine, Christopher P. Venner, Ian Paterson, Jeffrey Bakal, Cynthia Westerhout, Finlay A. Mcalister, Padma Kaul & Justin A. Ezekowitz. (2022) The Incidence and Prevalence of Cardiac Amyloidosis in a Large Community-Based Cohort in Alberta, Canada. Journal of Cardiac Failure 28:2, pages 237-246.
Crossref
Crossref
Sabine Pankuweit & Rolf Dörr. (2021) Diagnose und Behandlung der kardialen AmyloidoseDiagnosis and treatment of cardiac amyloidosis. Herz 47:1, pages 41-47.
Crossref
Crossref
Nobuhiro Tahara, Olivier Lairez, Jin Endo, Atsushi Okada, Mitsuharu Ueda, Tomonori Ishii, Yoshinobu Kitano, Hahn‐Ey Lee, Eleonora Russo & Toru Kubo. (2021)
99m
Technetium‐pyrophosphate scintigraphy: a practical guide for early diagnosis of transthyretin amyloid cardiomyopathy
. ESC Heart Failure 9:1, pages 251-262.
Crossref
Crossref
Kush P Patel, Paul Richard Scully, Christian Nitsche, Andreas A Kammerlander, George Joy, George Thornton, Rebecca Hughes, Suzanne Williams, Therese Tillin, Gabriella Captur, Liza Chacko, Andrew Kelion, Nikant Sabharwal, James D Newton, Simon Kennon, Mick Ozkor, Michael Mullen, Philip N Hawkins, Julian D Gillmore, Leon Menezes, Francesca Pugliese, Alun D Hughes, Marianna Fontana, Guy Lloyd, Thomas A Treibel, Julia Mascherbauer & James C Moon. (2022) Impact of afterload and infiltration on coexisting aortic stenosis and transthyretin amyloidosis. Heart 108:1, pages 67-72.
Crossref
Crossref
Hideomi Hamasaki, Masahiro Shijo, Ayaka Nakamura, Hiroyuki Honda, Yuichi Yamada, Yoshinao Oda, Tomoyuki Ohara, Toshiharu Ninomiya & Toru Iwaki. (2021) Concurrent cardiac transthyretin and brain β amyloid accumulation among the older adults: The Hisayama study. Brain Pathology 32:1.
Crossref
Crossref
Michele Lioncino, Emanuele Monda, Giuseppe Palmiero, Martina Caiazza, Erica Vetrano, Marta Rubino, Augusto Esposito, Gemma Salerno, Francesca Dongiglio, Barbara D’Onofrio, Federica Verrillo, Giuseppe Cerciello, Fiore Manganelli, Giuseppe Pacileo, Eduardo Bossone, Paolo Golino, Paolo Calabrò & Giuseppe Limongelli. (2022) Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis. Heart Failure Clinics 18:1, pages 73-87.
Crossref
Crossref
Richard M. Giadone, Sabrina Ghosh & George J. Murphy. 2022. Novel Concepts in iPSC Disease Modeling. Novel Concepts in iPSC Disease Modeling
105
122
.
Elisabete Ferreira, Zaida L. Almeida, Pedro F. Cruz, Marta Silva e Sousa, Paula Veríssimo & Rui M. M. Brito. (2021) Searching for the Best Transthyretin Aggregation Protocol to Study Amyloid Fibril Disruption. International Journal of Molecular Sciences 23:1, pages 391.
Crossref
Crossref
Edward J Butt & Michael C Boyars. (2021) An Unusual Case of Heart Failure: Sometimes When You Hear Hoof Beats You Should Think of Zebras. Cureus.
Crossref
Crossref
Marcelo Kirschbaum, Aristóteles Conte AlencarNetoNeto, Vitor Emer de Egypto Rosa, Félix José Alvarez Ramires, Alexandre Antonio Cunha Abizaid, Fábio Sandoli de BritoJuniorJunior, Flávio Tarasoutchi, Roberto KalilFilhoFilho & Fábio Fernandes. (2021) Cardiac Amyloidosis and Aortic Stenosis: When to Consider it and How to Treat it?. ABC: Heart Failure & Cardiomyopathy 1:2, pages 90-94.
Crossref
Crossref
Tonnison Silva, Carlos Eduardo Lucena Montenegro, Marcelo Dantas Tavares de Melo, Luiz Ritt & André Luiz Cerqueira Almeida. (2021) New Paradigms in Cardiac Amyloidosis: The Current Experience of the Northeast Region of Brazil. ABC: Heart Failure & Cardiomyopathy 1:2, pages 112-114.
Crossref
Crossref
Yousuf Razvi, Rishi K. Patel, Marianna Fontana & Julian D. Gillmore. (2021) Cardiac Amyloidosis: A Review of Current Imaging Techniques. Frontiers in Cardiovascular Medicine 8.
Crossref
Crossref
Ivana Slamova, Rozita Adib, Stephan Ellmerich, Michal R. Golos, Janet A. Gilbertson, Nicola Botcher, Diana Canetti, Graham W. Taylor, Nigel Rendell, Glenys A. Tennent, Guglielmo Verona, Riccardo Porcari, P. Patrizia Mangione, Julian D. Gillmore, Mark B. Pepys, Vittorio Bellotti, Philip N. Hawkins, Raya Al-Shawi & J. Paul Simons. (2021) Plasmin activity promotes amyloid deposition in a transgenic model of human transthyretin amyloidosis. Nature Communications 12:1.
Crossref
Crossref
Asan Agibetov, Andreas Kammerlander, Franz Duca, Christian Nitsche, Matthias Koschutnik, Carolina Donà, Theresa-Marie Dachs, René Rettl, Alessa Stria, Lore Schrutka, Christina Binder, Johannes Kastner, Hermine Agis, Renate Kain, Michaela Auer-Grumbach, Matthias Samwald, Christian Hengstenberg, Georg Dorffner, Julia Mascherbauer & Diana Bonderman. (2021) Convolutional Neural Networks for Fully Automated Diagnosis of Cardiac Amyloidosis by Cardiac Magnetic Resonance Imaging. Journal of Personalized Medicine 11:12, pages 1268.
Crossref
Crossref
Chao Ren, Jingyun Ren, Zhuang Tian, Yanrong Du, Zhixin Hao, Zongyao Zhang, Wei Fang, Fang Li, Shuyang Zhang, Bailing Hsu & Li Huo. (2021) Assessment of cardiac amyloidosis with 99mTc-pyrophosphate (PYP) quantitative SPECT. EJNMMI Physics 8:1.
Crossref
Crossref
Simona Ben-Haim, A. Chicheportiche, E. Goshen, M. Arad, M. Smekhov, L. J. Menezes, P. M. Elliott, E. O’Mahoney, E. Stern, Bella Yuzefovich & J. B. Bomanji. (2021) Quantitative SPECT/CT parameters of myocardial 99mTechnetium-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) uptake in suspected cardiac transthyretin amyloidosis. EJNMMI Research 11:1.
Crossref
Crossref
Felix D. Nguyen, Mario Rodriguez, Chayakrit Krittanawong, Ronald Witteles & Daniel J. Lenihan. (2021) Misconceptions and Facts About Cardiac Amyloidosis. The American Journal of Cardiology 160, pages 99-105.
Crossref
Crossref
Kshama Wechalekar & Ashutosh D. Wechalekar. (2020) Wild-type transthyretin cardiac amyloidosis: When is a rare disease no longer a rare disease?. Journal of Nuclear Cardiology 28:6, pages 2857-2859.
Crossref
Crossref
Claire Cuscaden, Stuart C. Ramsay, Sandhir Prasad, Bruce Goodwin & Jye Smith. (2020) Estimation of prevalence of transthyretin (ATTR) cardiac amyloidosis in an Australian subpopulation using bone scans with echocardiography and clinical correlation. Journal of Nuclear Cardiology 28:6, pages 2845-2856.
Crossref
Crossref
Alberta L. Warner. (2021) Advances in the treatment of transthyretin cardiac amyloidosis: Current and emerging therapies. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 41:12, pages 1081-1091.
Crossref
Crossref
Sara Shimoni, Meital Zikri, Dan Haberman, Shay Livschitz, Sagi Tshori, Yacov Fabricant, Valery Meledin, Gera Gandelman, Sorel Goland & Jacob George. (2021) Transthyretin cardiac amyloidosis in patients after TAVR: clinical and echocardiographic findings and long term survival. ESC Heart Failure 8:6, pages 4549-4561.
Crossref
Crossref
Aldostefano Porcari, Rossana Bussani, Marco Merlo, Guerino Giuseppe Varrà, Linda Pagura, Davide Rozze & Gianfranco Sinagra. (2021) Incidence and Characterization of Concealed Cardiac Amyloidosis Among Unselected Elderly Patients Undergoing Post-mortem Examination. Frontiers in Cardiovascular Medicine 8.
Crossref
Crossref
Svetlana A. Boldueva, Dmitriy S. Evdokimov, Natalia S. Shvets, Anahit V. Shahbazyan, Elena Yu. Kalinina & Lyubov B. Mitrofanova. (2021) Systemic transtiretin amyloidosis in the elderly patient with recurrent pleural effusions. HERALD of North-Western State Medical University named after I.I. Mechnikov 13:3, pages 91-98.
Crossref
Crossref
Gioele Fabbri, Matteo Serenelli, Anna Cantone, Federico Sanguettoli & Claudio Rapezzi. (2021) Transthyretin amyloidosis in aortic stenosis: clinical and therapeutic implications. European Heart Journal Supplements 23:Supplement_E, pages E128-E132.
Crossref
Crossref
Aayush Kumar Singal, Raghav Bansal, Avinainder Singh, Sharmila Dorbala, Gautam Sharma, Kartik Gupta, Anita Saxena, Balram Bhargava, Ganesan Karthikeyan, Sivasubramanian Ramakrishnan, Akshay Kumar Bisoi, Milind Padmakar Hote, Palleti Rajashekar, Ujjwal Kumar Chowdhury, Velayoudam Devagourou, Chetan Patel, Ruma Ray, Sudheer Kumar Arawa & Sundeep Mishra. (2021) Concomitant Transthyretin Amyloidosis and Severe Aortic Stenosis in Elderly Indian Population. JACC: CardioOncology 3:4, pages 565-576.
Crossref
Crossref
Anthony J. Kanelidis, Patrick Miller, Nicole Prabhu, Mark Joshua Dela Cruz, Francis J. Alenghat, Phillip McMullenIIII, Nitasha Sarswat, Benjamin A. Derman, Tamar S. Polonsky & Jeanne M. DeCara. (2021) ATTR Cardiomyopathy Meets Multiple Myeloma. JACC: CardioOncology 3:4, pages 598-601.
Crossref
Crossref
Oscar Westin, Jawad H. Butt, Finn Gustafsson, Morten Schou, Morten Salomo, Lars Køber, Mathew Maurer & Emil L. Fosbøl. (2021) Two Decades of Cardiac Amyloidosis. JACC: CardioOncology 3:4, pages 522-533.
Crossref
Crossref
Zack Dale, Pranav Chandrashekar, Lana Al-Rashdan, Morris Kim, Ahmad Masri & Babak Nazer. (2021) Management Strategies for Atrial Fibrillation and Flutter in Patients with Transthyretin Cardiac Amyloidosis. The American Journal of Cardiology 157, pages 107-114.
Crossref
Crossref
Gary R. Small, Anthony Poulin, Anahita Tavoosi, Toby D. Small, Andrew M. Crean & Benjamin J. W. Chow. (2021) Cardiac Computed Tomography for Amyloidosis. Current Cardiovascular Imaging Reports 14:10.
Crossref
Crossref
Marcus V. Simões, Fabio Fernandes, Fabiana G. Marcondes-Braga, Philip Scheinberg, Edileide de Barros Correia, Luis Eduardo P. Rohde, Fernando Bacal, Silvia Marinho Martins Alves, Sandrigo Mangini, Andréia Biolo, Luis Beck-da-Silva, Roberta Shcolnik Szor, Wilson MarquesJuniorJunior, Acary Souza Bulle Oliveira, Márcia Waddington Cruz, Bruno Vaz Kerges Bueno, Ludhmila Abrahão Hajjar, Aurora Felice Castro Issa, Felix José Alvarez Ramires, Otavio Rizzi CoelhoFilhoFilho, André Schmidt, Ibraim Masciarelli Francisco Pinto, Carlos Eduardo Rochitte, Marcelo Luiz Campos Vieira, Cláudio Tinoco Mesquita, Celso Dario Ramos, José Soares-Junior, Minna Moreira Dias Romano, Wilson MathiasJuniorJunior, Marcelo Iório GarciaJuniorJunior, Marcelo Westerlund Montera, Marcelo Dantas Tavares de Melo, Sandra Marques e Silva, Pedro Manoel Marques Garibaldi, Aristóteles Comte de AlencarNetoNeto, Renato Delascio Lopes, Diane Xavier de Ávila, Denizar Viana, José Francisco Kerr Saraiva, Manoel Fernandes Canesin, Glaucia Maria Moraes de Oliveira & Evandro Tinoco Mesquita. (2021) Posicionamento sobre Diagnóstico e Tratamento da Amiloidose Cardíaca – 2021. Arquivos Brasileiros de Cardiologia 117:3, pages 561-598.
Crossref
Crossref
John A Johnson, Kazi T Haq, Katherine J Lutz, Kyle K Peters, Kevin A Paternostro, Natalie E Craig, Nathan W L Stencel, Lila F Hawkinson, Maedeh Khayyat-Kholghi & Larisa G Tereshchenko. (2021) Electrophysiological ventricular substrate of stroke: a prospective cohort study in the Atherosclerosis Risk in Communities (ARIC) study. BMJ Open 11:9, pages e048542.
Crossref
Crossref
Matthew Capustin & William H. Frishman. (2021) Transthyretin Cardiac Amyloidosis and Novel Therapies to Treat This Not-so-rare Cause of Cardiomyopathy. Cardiology in Review 29:5, pages 263-273.
Crossref
Crossref
Masayoshi Tasaki, Francesca Lavatelli, Laura Obici, Konen Obayashi, Takeshi Miyamoto, Giampaolo Merlini, Giovanni Palladini, Yukio Ando & Mitsuharu Ueda. (2021) Age-related amyloidosis outside the brain: A state-of-the-art review. Ageing Research Reviews 70, pages 101388.
Crossref
Crossref
Yuri Ochi, Toru Kubo, Yuichi Baba, Kenta Sugiura, Motoko Ueda, Kazuya Miyagawa, Tatsuya Noguchi, Takayoshi Hirota, Tomoyuki Hamada, Naohito Yamasaki & Hiroaki Kitaoka. (2021) Wild-Type Transthyretin Amyloidosis in Female Patients ― Consideration of Sex Differences ―. Circulation Reports 3:8, pages 465-471.
Crossref
Crossref
Shojiro Ichimata, Yukiko Hata & Naoki Nishida. (2021) Effects of sporadic transthyretin amyloidosis frequently on the gallbladder and the correlation between amyloid deposition in the gallbladder and heart: A forensic autopsy‐based histopathological evaluation. Pathology International 71:8, pages 530-537.
Crossref
Crossref
Alex Smith, D. Balmforth, T. A. Treibel, Kulvinder Lall, Aung Oo & Shirish Ambekar. (2021) Cardiac amyloidosis in non‐transplant cardiac surgery. Journal of Cardiac Surgery 36:8, pages 2901-2910.
Crossref
Crossref
Steven Law, Marianna Fontana & Julian D. Gillmore. (2021) Advances in Diagnosis and Treatment of Cardiac and Renal Amyloidosis. Cardiology Clinics 39:3, pages 389-402.
Crossref
Crossref
Takayuki Inomata, Nobuhiro Tahara, Kazufumi Nakamura, Jin Endo, Mitsuharu Ueda, Tomonori Ishii, Yoshinobu Kitano & Jun Koyama. (2021) Diagnosis of wild‐type transthyretin amyloid cardiomyopathy in Japan: red‐flag symptom clusters and diagnostic algorithm. ESC Heart Failure 8:4, pages 2647-2659.
Crossref
Crossref
Robert Daniel Adam, Daniel Coriu, Andreea Jercan, Sorina Bădeliţă, Bogdan A. Popescu, Thibaud Damy & Ruxandra Jurcuţ. (2021) Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature. ESC Heart Failure 8:4, pages 2380-2396.
Crossref
Crossref
Cristina Chimenti, Maria Alfarano, Viviana Maestrini, Nicola Galea, Giuseppe De Vincentis, Romina Verardo, Francesco Fedele & Andrea Frustaci. (2021) False‐positive bone scintigraphy denoting transthyretin amyloid in elderly hypertrophic cardiomyopathy. ESC Heart Failure 8:4, pages 3387-3391.
Crossref
Crossref
Sarah Ming Li Tan, Yoke Ching Lim, Ping Chai, Lenith Tai Jit Cheng, Ching Hui Sia, Raymond Ching Chiew Wong, Hoi Yin Loi & Weiqin Lin. (2021) Transthyretin amyloid cardiomyopathy: The emerging role of cardiac
amyloid imaging. Annals of the Academy of Medicine, Singapore 50:7, pages 566-571.
Crossref
Crossref
Zoltán Pozsonyi, Gergely Peskó, Hedvig Takács, Dorottya Csuka, Viktória Nagy, Ágnes Szilágyi, Lidia Hategan, Balázs Muk, Beáta Csányi, Noémi Nyolczas, Lívia Dézsi, Judit Mária Molnár, Anita Csillik, Katalin Révész, Béla Iványi, Fruzsina Szabó, Krisztián Birtalan, Tamás Masszi, Zsuzsanna Arányi & Róbert Sepp. (2021) Variant Transthyretin Amyloidosis (ATTRv) in Hungary: First Data on Epidemiology and Clinical Features. Genes 12:8, pages 1152.
Crossref
Crossref
Ravi F. Sood, Srdjan Kamenko, Eleanor McCreary, Bergen K. Sather, Michael Schmitt, Steven L. Peterson & Angelo B. Lipira. (2021) Diagnosing Systemic Amyloidosis Presenting as Carpal Tunnel Syndrome. Journal of Bone and Joint Surgery 103:14, pages 1284-1294.
Crossref
Crossref
Mattia Zampieri, Giulia Nardi, Guido Del Monaco, Marco Allinovi, Martina Gabriele, Chiara Zocchi, Silvia Casagrande, Carlo Fumagalli, Carlo Di Mario, Iacopo Olivotto, Federico Perfetto & Francesco Cappelli. (2021) Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in Tuscany. International Journal of Cardiology 335, pages 123-127.
Crossref
Crossref
Marcus V. Pinto, P. James B. Dyck & Teerin Liewluck. (2021) Neuromuscular amyloidosis: Unmasking the master of disguise. Muscle & Nerve 64:1, pages 23-36.
Crossref
Crossref
Hani Sabbour, Khwaja Yousuf Hasan, Firas Al Badarin, Haluk Alibazoglu, Andrew L. Rivard, Ingy Romany & Stefano Perlini. (2021) From Clinical Clues to Final Diagnosis: The Return of Detective Work to Clinical Medicine in Cardiac Amyloidosis. Frontiers in Cardiovascular Medicine 8.
Crossref
Crossref
Viktor Löfbacka, Ole B. Suhr, Bjorn Pilebro, Jonas Wixner, Torbjorn Sundström, Krister Lindmark, Intissar Anan & Per Lindqvist. (2021) Combining ECG and echocardiography to identify transthyretin cardiac amyloidosis in heart failure. Clinical Physiology and Functional Imaging.
Crossref
Crossref
Kenta Sugiura, Hiroki Kozuki, Hiroaki Ueba, Toru Kubo, Yuri Ochi, Yuichi Baba, Kazuya Miyagawa, Tatsuya Noguchi, Takayoshi Hirota, Naohito Yamasaki, Noriko Wada, Junko Nakashima, Ichiro Murakami, Masahiko Ikeuchi & Hiroaki Kitaoka. (2021) Tenosynovial and Cardiac Transthyretin Amyloidosis in Japanese Patients Undergoing Carpal Tunnel Release. Circulation Reports 3:6, pages 338-344.
Crossref
Crossref
Diana Lelli, Claudio Pedone, Dario Leosco & Raffaele Antonelli Incalzi. (2021) Cardiac amyloidosis awareness among residents/specialists in Geriatrics: an Italian national survey. Journal of Gerontology and Geriatrics 69:3, pages 177-187.
Crossref
Crossref
Timothy J. Poterucha, Pierre Elias, Sabahat Bokhari, Andrew J. Einstein, Albert DeLuca, Mona Kinkhabwala, Lynne L. Johnson, Kathleen R. Flaherty, Sunil E. Saith, Jan M. Griffin, Adler Perotte & Mathew S. Maurer. (2021) Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate. JACC: Cardiovascular Imaging 14:6, pages 1221-1231.
Crossref
Crossref
Viktor Löfbacka, Jan Axelsson, Björn Pilebro, Ole B. Suhr, Per Lindqvist & Torbjörn Sundström. (2020) Cardiac transthyretin amyloidosis 99mTc-DPD SPECT correlates with strain echocardiography and biomarkers. European Journal of Nuclear Medicine and Molecular Imaging 48:6, pages 1822-1832.
Crossref
Crossref
Weijia Li, Dipan Uppal, Yu Chiang Wang, Xiaobo Xu, Damianos G. Kokkinidis, Mark I. Travin & James M. Tauras. (2021) Nuclear Imaging for the Diagnosis of Cardiac Amyloidosis in 2021. Diagnostics 11:6, pages 996.
Crossref
Crossref
Fabiana G. Marcondes-Braga, Lídia Ana Zytynski Moura, Victor Sarli Issa, Jefferson Luis Vieira, Luis Eduardo Rohde, Marcus Vinícius Simões, Miguel Morita Fernandes-Silva, Salvador Rassi, Silvia Marinho Martins Alves, Denilson Campos de Albuquerque, Dirceu Rodrigues de Almeida, Edimar Alcides Bocchi, Felix José Alvarez Ramires, Fernando Bacal, João Manoel RossiNetoNeto, Luiz Claudio Danzmann, Marcelo Westerlund Montera, Mucio Tavares de OliveiraJuniorJunior, Nadine Clausell, Odilson Marcos Silvestre, Reinaldo Bulgarelli Bestetti, Sabrina Bernadez-Pereira, Aguinaldo F. FreitasJrJr, Andréia Biolo, Antonio Carlos Pereira Barretto, Antônio José Lagoeiro Jorge, Bruno Biselli, Carlos Eduardo Lucena Montenegro, Edval Gomes dos SantosJúniorJúnior, Estêvão Lanna Figueiredo, Fábio Fernandes, Fabio Serra Silveira, Fernando Antibas Atik, Flávio de Souza Brito, Germano Emílio Conceição Souza, Gustavo Calado de Aguiar Ribeiro, Humberto Villacorta, João David de SouzaNetoNeto, Livia Adams Goldraich, Luís Beck-da-Silva, Manoel Fernandes Canesin, Marcelo Imbroinise Bittencourt, Marcely Gimenes Bonatto, Maria da Consolação Vieira Moreira, Mônica Samuel Avila, Otavio Rizzi CoelhoFilhoFilho, Pedro Vellosa Schwartzmann, Ricardo Mourilhe-Rocha, Sandrigo Mangini, Silvia Moreira Ayub Ferreira, José Albuquerque de FigueiredoNetoNeto & Evandro Tinoco Mesquita. (2021) Atualização de Tópicos Emergentes da Diretriz Brasileira de Insuficiência Cardíaca – 2021. Arquivos Brasileiros de Cardiologia.
Crossref
Crossref
Aubin Michalon, Andreas Hagenbuch, Christian Huy, Evita Varela, Benoit Combaluzier, Thibaud Damy, Ole B. Suhr, Maria J. Saraiva, Christoph Hock, Roger M. Nitsch & Jan Grimm. (2021) A human antibody selective for transthyretin amyloid removes cardiac amyloid through phagocytic immune cells. Nature Communications 12:1.
Crossref
Crossref
Sonia Podvin, Alexander Jones, Qing Liu, Brent Aulston, Charles Mosier, Janneca Ames, Charisse Winston, Christopher B. Lietz, Zhenze Jiang, Anthony J. O’Donoghue, Tsuneya Ikezu, Robert A. Rissman, Shauna H. Yuan & Vivian Hook. (2021) Mutant Presenilin 1 Dysregulates Exosomal Proteome Cargo Produced by Human-Induced Pluripotent Stem Cell Neurons. ACS Omega 6:20, pages 13033-13056.
Crossref
Crossref
M. Hasib Sidiqi & Morie A. Gertz. (2021) Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021. Blood Cancer Journal 11:5.
Crossref
Crossref
Shinichi Goto, Keitaro Mahara, Lauren Beussink-Nelson, Hidehiko Ikura, Yoshinori Katsumata, Jin Endo, Hanna K. Gaggin, Sanjiv J. Shah, Yuji Itabashi, Calum A. MacRae & Rahul C. Deo. (2021) Artificial intelligence-enabled fully automated detection of cardiac amyloidosis using electrocardiograms and echocardiograms. Nature Communications 12:1.
Crossref
Crossref
Robert Adam, Gabriela Neculae, Claudiu Stan & Ruxandra Jurcut. (2021) Current Challenges of Cardiac Amyloidosis Awareness among Romanian Cardiologists. Diagnostics 11:5, pages 834.
Crossref
Crossref
Francis T Delaney, Philip Dempsey, Ivan Welaratne, Bryan Buckley, Donagh O'Sullivan & Martin O'Connell. (2021) Incidental cardiac uptake in bone scintigraphy: increased importance and association with cardiac amyloidosis. BJR|case reports 7:3, pages 20200161.
Crossref
Crossref
João Abecasis, Daniel Gomes Pinto, Sância Ramos, Pier Giorgio Masci, Nuno Cardim, Victor Gil & Ana Félix. (2021) Left Ventricular Remodeling in Degenerative Aortic Valve Stenosis. Current Problems in Cardiology 46:5, pages 100801.
Crossref
Crossref
Lily K. Stern & Michelle M. Kittleson. (2021) Updates in Cardiac Amyloidosis Diagnosis and Treatment. Current Oncology Reports 23:4.
Crossref
Crossref
Maike F. Dohrn, Sandra Ihne, Ute Hegenbart, Jessica Medina, Stephan L. Züchner, Teresa Coelho & Katrin Hahn. (2020) Targeting transthyretin ‐ Mechanism‐based treatment approaches and future perspectives in hereditary amyloidosis. Journal of Neurochemistry 156:6, pages 802-818.
Crossref
Crossref
Elsa Poullot, Silvia Oghina, Sarah Kalsoum & Thibaud Damy. (2021) Les amyloses cardiaques. Annales de Pathologie 41:1, pages 25-37.
Crossref
Crossref
Claudio Rapezzi, Francesco Giannini & Gianluca Campo. (2020) Aortic stenosis, transcatheter aortic valve replacement and transthyretin cardiac amyloidosis: are we progressively unraveling the tangle?. European Journal of Heart Failure 23:2, pages 259-263.
Crossref
Crossref
Maxime Beneyto, Eve Cariou, Jérémy Brunel, Alex Scripcariu, Hubert Delasnerie, Stéphanie Brun, Yoan Lavie-Badie, Delphine Dupin Deguine, Michel Galinier, Didier Carrié & Olivier Lairez. (2021) Tip of the iceberg: a tertiary care centre retrospective study of left ventricular hypertrophy aetiologies. Open Heart 8:1, pages e001462.
Crossref
Crossref
Francisca Pinheiro, Nathalia Varejão, Sebastian Esperante, Jaime Santos, Adrián Velázquez‐Campoy, David Reverter, Irantzu Pallarès & Salvador Ventura. (2020) Tolcapone, a potent aggregation inhibitor for the treatment of familial leptomeningeal amyloidosis. The FEBS Journal 288:1, pages 310-324.
Crossref
Crossref
Francesco Cappelli, Federico Perfetto, Raffaele Martone & Carlo Di Mario. (2021) Cardiac Amyloidosis in Patients Undergoing TAVR: Why We Need to Think About It. Cardiovascular Revascularization Medicine 22, pages 109-114.
Crossref
Crossref
Cindy Varga, Sharmila Dorbala, Isabelle Lousada, Michael J. Polydefkis, Ashutosh Wechalekar, Mathew S. Maurer & Raymond L. Comenzo. (2021) The diagnostic challenges of cardiac amyloidosis: A practical approach to the two main types. Blood Reviews 45, pages 100720.
Crossref
Crossref
Evan T. Powers & Jeffery W. Kelly. 2021. Neurotherapeutics in the Era of Translational Medicine. Neurotherapeutics in the Era of Translational Medicine
65
103
.
Priscila Cestari Quagliato. 2021. Nuclear Cardiology. Nuclear Cardiology
419
436
.
Rafael Vidal-Perez, Raquel Vázquez-García, Gonzalo Barge-Caballero, Alberto Bouzas-Mosquera, Rafaela Soler-Fernandez, Jose Maria Larrañaga-Moreira, Maria Generosa Crespo-Leiro & Jose Manuel Vazquez-Rodriguez. (2020) Diagnostic and prognostic value of cardiac imaging in amyloidosis. World Journal of Cardiology 12:12, pages 599-614.
Crossref
Crossref
Hedvig Paulsson Rokke, Nima Sadat Gousheh, Per Westermark, Ole B. Suhr, Intissar Anan, Elisabet Ihse, Björn Pilebro & Jonas Wixner. (2020) Abdominal fat pad biopsies exhibit good diagnostic accuracy in patients with suspected transthyretin amyloidosis. Orphanet Journal of Rare Diseases 15:1.
Crossref
Crossref
Morie Gertz, David Adams, Yukio Ando, João Melo Beirão, Sabahat Bokhari, Teresa Coelho, Raymond L. Comenzo, Thibaud Damy, Sharmila Dorbala, Brian M. Drachman, Marianna Fontana, Julian D. Gillmore, Martha Grogan, Philip N. Hawkins, Isabelle Lousada, Arnt V. Kristen, Frederick L. Ruberg, Ole B. Suhr, Mathew S. Maurer, Jose Nativi-Nicolau, Candida Cristina Quarta, Claudio Rapezzi, Ronald Witteles & Giampaolo Merlini. (2020) Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner. BMC Family Practice 21:1.
Crossref
Crossref
Vittorio D’Aguanno, Massimo Ralli, Marco Artico, Francesca Yoshie Russo, Alfonso Scarpa, Marco Fiore, Paola Tirassa, Cinzia Severini, Marco de Vincentiis & Antonio Greco. (2019) Systemic Amyloidosis: a Contemporary Overview. Clinical Reviews in Allergy & Immunology 59:3, pages 304-322.
Crossref
Crossref
Diana Bonderman, Gerhard Pölzl, Klemens Ablasser, Hermine Agis, Stefan Aschauer, Michaela Auer-Grumbach, Christina Binder, Jakob Dörler, Franz Duca, Christian Ebner, Marcus Hacker, Renate Kain, Andreas Kammerlander, Matthias Koschutnik, Alexander Stephan Kroiss, Agnes Mayr, Christian Nitsche, Peter P. Rainer, Susanne Reiter-Malmqvist, Matthias Schneider, Roland Schwarz, Nicolas Verheyen, Thomas Weber, Marc Michael Zaruba, Roza Badr Eslam, Martin Hülsmann & Julia Mascherbauer. (2020) Diagnosis and treatment of cardiac amyloidosis: an interdisciplinary consensus statement. Wiener klinische Wochenschrift 132:23-24, pages 742-761.
Crossref
Crossref
Florian Kocher, Alex Kaser, Felix Escher, Jacob Doerler, Marc‐Michael Zaruba, Moritz Messner, Christine Mussner‐Seeber, Agnes Mayr, Hanno Ulmer, Stephanie Schneiderbauer‐Porod, Christian Ebner & Gerhard Poelzl. (2020) Heart failure from ATTRwt amyloid cardiomyopathy is associated with poor prognosis. ESC Heart Failure 7:6, pages 3919-3928.
Crossref
Crossref
Marcus Vinicius Simões, Silvia Marinho Martins Alves, Fabio Fernandes, Otávio Rizzi CoelhoFilhoFilho & Sandrigo Mangini. (2020) Tópicos Emergentes em Insuficiência Cardíaca: Novos Paradigmas na Amiloidose Cardíaca. Arquivos Brasileiros de Cardiologia 115:5, pages 945-948.
Crossref
Crossref
Celia M. Torres-Arancivia, Deborah Chang, William E. Hackett, Joseph Zaia & Lawreen H. Connors. (2020) Glycosylation of Serum Clusterin in Wild-Type Transthyretin-Associated (ATTRwt) Amyloidosis: A Study of Disease-Associated Compositional Features Using Mass Spectrometry Analyses. Biochemistry 59:45, pages 4367-4378.
Crossref
Crossref
Daniele Pasqualucci, Attilio Iacovoni, Vittorio Palmieri, Renata De Maria, Massimo Iacoviello, Ilaria Battistoni, Francesca Macera, Iacopo Olivotto, Eloisa Arbustini & Andrea Mortara. (2020) Epidemiology of cardiomyopathies: essential context knowledge for a tailored clinical work-up. European Journal of Preventive Cardiology.
Crossref
Crossref
Chun Shing Kwok, Afshin Farzaneh-Far & Mamas A Mamas. (2020) Red flags in cardiac amyloidosis. European Journal of Preventive Cardiology 27:17, pages 1804-1805.
Crossref
Crossref
Giuseppe Vergaro, Alberto Aimo, Andrea Barison, Dario Genovesi, Gabriele Buda, Claudio Passino & Michele Emdin. (2020) Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings. European Journal of Preventive Cardiology 27:17, pages 1806-1815.
Crossref
Crossref
E. N. Proshkina, I. A. Solovev, M. V. Shaposhnikov & A. A. Moskalev. (2021) Key Molecular Mechanisms of Aging, Biomarkers, and Potential Interventions. Molecular Biology 54:6, pages 777-811.
Crossref
Crossref
Hiroyuki Kato, Osamu Igawa, Kazumasa Suga, Hisashi Murakami, Kenji Kada, Naoya Tsuboi, Satoshi Yanagisawa, Yasuya Inden & Toyoaki Murohara. (2020) Autopsy evaluation of the implantation site of a His bundle pacing lead demonstrating selective capture. Pacing and Clinical Electrophysiology 43:11, pages 1412-1416.
Crossref
Crossref
Hiroki Usuku, Seiji Takashio, Eiichiro Yamamoto, Yui Kinoshita, Masato Nishi, Fumi Oike, Kyohei Marume, Kyoko Hirakawa, Noriaki Tabata, Seitaro Oda, Yohei Misumi, Mitsuharu Ueda, Hiroaki Kawano, Koichi Kaikita, Kenichi Matsushita, Yukio Ando, Hirotaka Matsui & Kenichi Tsujita. (2020)
Usefulness of relative apical longitudinal strain index to predict positive
99m
Tc‐labeled pyrophosphate scintigraphy findings in advanced‐age patients with suspected transthyretin amyloid cardiomyopathy
. Echocardiography 37:11, pages 1774-1783.
Crossref
Crossref
Miguel Lorenzo, Rafael de la Espriella, Gema Miñana, Gonzalo Núñez, Enrique Santas, Eduardo Núñez, Raquel Heredia, Anna Mollar, Jose Civera, Amparo Villaescusa, Clara Sastre, Adriana Conesa, Clara Bonanad, Antoni Bayés-Genís & Julio Núñez. (2020) Clinical profile and 1-year clinical outcomes of super elderly patients admitted with acute heart failure. European Journal of Internal Medicine 81, pages 78-82.
Crossref
Crossref
Gabriela Spencer-Bonilla, Kevin M. Alexander & Ronald M. Witteles. (2020) Advances in the Diagnosis and Management of Transthyretin Amyloid Cardiomyopathy. Current Treatment Options in Cardiovascular Medicine 22:11.
Crossref
Crossref
Paul R. Scully, Kush P. Patel, Bunny Saberwal, Ernst Klotz, João B. Augusto, George D. Thornton, Rebecca K. Hughes, Charlotte Manisty, Guy Lloyd, James D. Newton, Nikant Sabharwal, Andrew Kelion, Simon Kennon, Muhiddin Ozkor, Michael Mullen, Neil Hartman, João L. Cavalcante, Leon J. Menezes, Philip N. Hawkins, Thomas A. Treibel, James C. Moon & Francesca Pugliese. (2020) Identifying Cardiac Amyloid in Aortic Stenosis. JACC: Cardiovascular Imaging 13:10, pages 2177-2189.
Crossref
Crossref
Jan M. Griffin & Mathew S. Maurer. (2020) Cardiac amyloidosis in severe aortic stenosis: we can find it but what should we do?. European Journal of Heart Failure 22:10, pages 1863-1865.
Crossref
Crossref
Sebastiaan HC Klaassen, Dirk J van Veldhuisen, Hans LA Nienhuis, Maarten P van den Berg, Bouke PC Hazenberg & Peter van der Meer. (2020) Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction?. Cardiac Failure Review 6.
Crossref
Crossref
Paul R Scully, Kush P Patel, Thomas A Treibel, George D Thornton, Rebecca K Hughes, Sucharitha Chadalavada, Michail Katsoulis, Neil Hartman, Marianna Fontana, Francesca Pugliese, Nikant Sabharwal, James D Newton, Andrew Kelion, Muhiddin Ozkor, Simon Kennon, Michael Mullen, Guy Lloyd, Leon J Menezes, Philip N Hawkins & James C Moon. (2020) Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology in patients referred for transcatheter aortic valve implantation. European Heart Journal 41:29, pages 2759-2767.
Crossref
Crossref
Andrew Xanthopoulos, Apostolos Dimos, Grigorios Giamouzis, Angeliki Bourazana, Alexandros Zagouras, Michail Papamichalis, Takeshi Kitai, John Skoularigis & Filippos Triposkiadis. (2020) Coexisting Morbidities in Heart Failure: No Robust Interaction with the Left Ventricular Ejection Fraction. Current Heart Failure Reports 17:4, pages 133-144.
Crossref
Crossref
Alice Nevone, Giampaolo Merlini & Mario Nuvolone. (2020) Treating Protein Misfolding Diseases: Therapeutic Successes Against Systemic Amyloidoses. Frontiers in Pharmacology 11.
Crossref
Crossref
Displaying 200 of 366 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list